Six-Year Contraceptive Efficacy and Continued Safety of a Levonorgestrel 52mg Intrauterine System.

07:00 EST 28th November 2019 | BioPortfolio

Summary of "Six-Year Contraceptive Efficacy and Continued Safety of a Levonorgestrel 52mg Intrauterine System."

To assess 6-year contraceptive efficacy and safety of a levonorgestrel 52mg intrauterine system (IUS). Study Design We assessed pregnancy rates through 72 months in women aged 16-35 years at enrollment and safety in all participants (aged 16-45 years, n=1751) in an ongoing 10-year phase-3 trial.


Journal Details

This article was published in the following journal.

Name: Contraception
ISSN: 1879-0518


DeepDyve research library

PubMed Articles [16068 Associated PubMed Articles listed on BioPortfolio]

Experience with same-day placement of the 52mg levonorgestrel-releasing intrauterine system.

Prescribing information for the levonorgestrel-releasing intrauterine system allows placement when the clinician is reasonably certain the patient is not pregnant. A six-item checklist aids clinicians...

Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year post-insertion: a systematic review and meta-analysis.

Changes in menstrual bleeding concern many users of the 52 mg Levonorgestrel Intrauterine System (LNG-IUS). Prescribing information for LNG-IUS devices describe an overall decrease in bleeding and spo...

Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis.

Epidemiological studies have shown that some hormonal contraceptive methods are associated with increased breast cancer risk, especially if used over long periods. Our objective was to conduct a syste...

Effectiveness and Safety of Extending Intrauterine Device Duration: A Systematic Review.

To systematically review the literature to determine if extended use of intrauterine devices including the copper or levonorgestrel intrauterine device beyond approved durations is effective and safe ...

Reactional changes in short-term levonorgestrel-releasing intrauterine system (lng-ius) use.

To evaluate endocervical and vaginal environment changes in women using a levonorgestrel-releasing intrauterine system (LNG-IUS).

Clinical Trials [13913 Associated Clinical Trials listed on BioPortfolio]

A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative).

The intrauterine device (IUD) is a long-term birth control method that has demonstrated high contraceptive efficacy and effectiveness due to its high compliance, adherence and persistence ...

GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China

The purpose of this study is to assess the efficacy, safety, bleeding pattern of low dose LNG (12 mg/ 24 hrs), delivered locally by a new intrauterine contraceptive system suitable for use...

Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study

This is a study on a new low dose levonorgestrel contraceptive intrauterine systems (LCS). The purpose of the study is to investigate which of the 2 administered doses is the effective i...

Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri

This study aims to compare the efficacy of LNG - IUD (Levonorgestrel releasing intrauterine device) Versus Low dose COCs (combined oral contraceptive pills) on management of heavy menstrua...

Comparing the Efficacy of Intrauterine Balloon and Intrauterine Contraceptive Device for the Therapy of Uterine Adhesion

This study was taken out to compare two mechanical devices (intrauterine balloon and intrauterine contraceptive device) in the therapy for intrauterine adhesions after hysteroscopic adhesi...

Medical and Biotech [MESH] Definitions

Intrauterine devices that release contraceptive agents.

Work that is the report of a pre-planned, usually controlled, clinical study of the safety and efficacy of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques based on a small number of healthy persons and conducted over the period of about a year in either the United States or a foreign country.

Intrauterine contraceptive devices that depend on the release of metallic copper.

A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.

Contraceptive devices placed high in the uterine fundus with a string extending from the device through the cervical as into the vagina. (UMDNS, 1999)

Quick Search

DeepDyve research library

Relevant Topics

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Searches Linking to this Article